Navigation Links
Echo Therapeutics Announces Positive Results from Symphony(TM) Transdermal Continuous Glucose Monitoring System Study at Tufts Medical Center
Date:3/13/2008

able if at least ninety-five percent (95%) of the data points fall within the A/B region, along with negligible or no D/E points. MARD is an error calculation tool that measures the average relative difference between Symphony and the reference measurements, on a percentage basis. A low MARD error, below 20%, is consistent with an accurate device.

Results

Using approximately 1200 hours of continuous data from Symphony and 482 reference BG measurements from the 25 subjects, Clarke Error Grid analysis of the study data showed that Echo's Symphony had over 97% of the data in the combined A and B areas with approximately 70% in the "A" region, 27% in the "B" region, and less than 3% in the "D" region. The MARD for the study was approximately 16%. A total of forty-nine (49) Symphony sensors were used during the study. There were no Symphony failures and no adverse events, indicating strong reliability of the Symphony for applications in the hospital critical care setting.

Conference Call and Webcast Information

The Company will host a conference call at 10:30 AM ET to discuss the data and an update of its pipeline. To access the conference call, please dial 866- 467-0407 (domestic) or 706-902-0164 (international) and reference the conference ID 39282879. A replay of the call will be available from 10:30 a.m. ET on March 13, until March 15, 2008, at midnight. To access the replay, please dial 800-642-1687 (domestic) or 706-645-9291 (international) and reference the conference ID 39282879. A live audio webcast of the call and the archived webcast will be available in the Investors section of the Echo Therapeutics website http://www.echotx.com.

About Echo Therapeutics

Echo Therapeutics is focused on specialty pharmaceuticals and medical devices. Echo is developing novel topical reformulations of FDA-approved products and non-invasive, wireless, transdermal continuous glucose monitori
'/>"/>

SOURCE Echo Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results
2. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Mutually Terminate Merger Agreement; Oracle Healthcare Acquisition Corp. Cancels Special Meeting
3. Bayer HealthCare and Juvaris BioTherapeutics Announce Major Licensing Agreement
4. Cell Therapeutics, Inc. Announces Issuance of $51.7 Million of New 2012 Convertible Senior Notes
5. Jeffrey Modell Foundation and Talecris Biotherapeutics Expand Diagnostic Services for Primary Immunodeficiencies at Lucile Packard Childrens Hospital at Stanford
6. Sirion Therapeutics Receives NDA Acceptance and Priority Review From the FDA for Durezol(TM) in the Treatment of Postoperative Ocular Inflammation
7. Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results
8. Prime Therapeutics Introduces Efficiency Program to Help Employers Understand How to Most Effectively Spend Pharmacy Dollars
9. Hyperion Therapeutics Announces Enrollment of First Patient in Phase 2 Clinical Trial in Patients With Hepatic Encephalopathy
10. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Agree in Principle to Amend Merger Agreement to Reduce Consideration by 15%
11. Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... The Heart Fit Clinic has increased a patient's ... heart rate of 150 beats versus 100 beats, this is a big deal," says ... give life back to patients with heart disease," he adds. People with angina are ...
(Date:7/31/2015)... NY and Rockport, ME (PRWEB) , ... July 31, 2015 , ... The alarm was ... op. , Glancing out of the window, he recalled that his equipment was set ... Chrystie Street tower, he jumped out of bed. , The photo speaks for itself. ...
(Date:7/31/2015)... ... July 31, 2015 , ... Florida Hospital Tampa has ... was developed for targeted delivery of fluids to selected sites in the peripheral ... Hospital Tampa with the device that provides direct, local delivery of chemotherapy to ...
(Date:7/31/2015)... ... July 31, 2015 , ... Burnaby ... post that encourages the understanding and treatment of ankle sprains. A common sports ... remedies. This can be dangerous if the condition augments and causes more disruption. ...
(Date:7/31/2015)... ... ... Patients with higher levels of a key protein are at greater risk ... led by researchers from the Icahn School of Medicine at Mount Sinai. The study, ... greater production of the related RNT1 protein, which caused kidney cells to self-destruct. ...
Breaking Medicine News(10 mins):Health News:Heart Fit Clinic Helps Patient Increase Fitness Level with External Counterpulsation 2Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 2Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 3Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 4Health News:Absolute PhysioCare & Sports Rehab Promotes Understanding & Treatment of Ankle Sprains 2Health News:Mount Sinai Researchers Find Key Gene Drives Kidney Disease Severity 2Health News:Mount Sinai Researchers Find Key Gene Drives Kidney Disease Severity 3
... for Public-Private Partnerships at The Henry M. Jackson Foundation ... to announce the recipients of the 2012 Heroes of ... excellence and selfless dedication to advancing medicine for our ... their families. The recipients will be honored at the ...
... 6, 2012 Discoveries made in the laboratories of ... the first time, advance to the clinical research stage ... Translational Research Institute for Metabolism and Diabetes (TRI). The ... in the brain, which appears to resolve obesity without ...
... MONDAY, March 5 (HealthDay News) -- New guidelines for colorectal ... the emphasis on individual risk. People at average risk ... 50, whereas people at high risk -- those with inflammatory ... disease -- should get screened starting at age 40 or ...
... Doctors are more likely to order imaging and other diagnostic ... to the test results, according to a new study. ... efficiency, researchers from Harvard Medical School found easy access to ... percent increase in imaging test orders. Computerization actually could be ...
... today issued a new guidance statement for colorectal cancer ... cancer-related deaths for men and women in the United ... in the March 6 issue of Annals of ... this guidance statement to present information to physicians and ...
... March 5 (HealthDay News) -- Patients suffering from advanced ... physicians, so everyone is on the same page with ... The advice is outlined in a "scientific statement" ... "For patients with advanced heart failure, the decision-making ...
Cached Medicine News:Health News:HJF Center announces Heroes of Military Medicine award recipients 2Health News:Sanford-Burnham research advances to patient studies at TRI 2Health News:Sanford-Burnham research advances to patient studies at TRI 3Health News:New Colon Cancer Screening Guidelines Focus on Individual Risk 2Health News:New Colon Cancer Screening Guidelines Focus on Individual Risk 3Health News:Computerization May Not Curb Medical Tests, Costs 2Health News:American College of Physicians releases new colorectal cancer screening guidance statement 2Health News:Heart Failure Patients Urged to Discuss Care With Docs 2
(Date:7/31/2015)... 2015  Xcelience, a contract development and manufacturing ... a structured cash investment in Powdersize, a ... micronization and powder size classification within the pharmaceutical ... while simultaneously adding a complete set of particle ... "As we continue to build ...
(Date:7/31/2015)... , July 31, 2015 ... decades of experience, the domestic pharmaceutical industry is strong, ... manufacture products to high international standards. One ... known is in sub-Saharan Africa: Morocco has quietly become ... South Africa . Indeed, Moroccan pharma ...
(Date:7/31/2015)... WAYNE, Pa. , July 31, 2015 /PRNewswire/ ... a fully integrated specialty pharmaceutical company focused on ... announced the closing of its previously announced underwritten ... stock at a public offering price of $11.25 ... the offering included 1,000,000 shares issued upon the ...
Breaking Medicine Technology:Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4
... Texas, Feb. 23, 2012   ULURU Inc. (NYSE ... Goods Certificate has been issued by the Therapeutic Goods ... Commenting on the approval in Australia, Kerry P. ... another important milestone in the worldwide commercialization of Altrazeal®.  ...
... Feb. 23, 2012 A new imaging efficiency ... Medicaid Services (CMS) to reduce CT scans in ... are performing CT scans inappropriately, according to a ... of Emergency Medicine ("Assessment of Medicare,s Imaging ...
Cached Medicine Technology:ULURU Inc. Announces Approval to Market Altrazeal® in Australia 2ULURU Inc. Announces Approval to Market Altrazeal® in Australia 3Government Rule Designed to Limit CT Scans in ERs Is Unreliable, Invalid and Inaccurate, Says ACEP 2
... F 265 is a highly accurate portable, waterproof ... temperature measurements. Temperature compensated pH results can be ... or a 3-in-1 electrode. • This GLP/GMP compliant ... a printer or a computer. Up to 100 ...
... Over-sized compressor. Triple pane thermal glass. ... System No plumbing required. Equipped with a ... on Parts & Labor and an Additional 4 ... as a chromatography unit which includes two access ...
... 3 slide doors, 12 shelves.Over-sized compressor. Triple ... interior lighting. Self-Contained System No plumbing required. ... Full One Year Warranty on Parts & Labor ... Also available as a chromatography unit ...
... 1 swing door 4 shelves. Over-sized ... doors. Fluorescent interior lighting. Self-Contained System ... foot cord. Full One Year Warranty on ... Warranty on Compressor. Also available as ...
Medicine Products: